	Emerging Techniques in the Treatment of Conjunctival Melanoma. Curr Ophthalmol Rep Li WJ, Venkateswaran N, Antonietti M, Qureshi S, Galor A, Karp CL. PMID: 40521590 [PubMed]
	First-in-human PET imaging and evaluation of melanin-targeted [(18)F]DMPY2 in malignant melanoma patients. Theranostics Yang Y, Zhou M, Zhao S, Long T, Chen N, Wang X, Li Y, Chen X, Chen J, Huang X, Chen D, Su J, Hu S, Chen X. PMID: 40521209 [PubMed - indexed for MEDLINE]
	Response to: Commentary on Maja Guberina et al.'s study of dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma. Radiother Oncol Guberina M, Rating P, Sokolenko E, Jabbarli L, Kiefer T, Biewald E, Guberina N, Fiorentzis M, Bechrakis N, Flühs D, Stuschke M. PMID: 40517843 [PubMed - as supplied by publisher]
	Commentary on Maja Guberina et al.'s study of dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma. Radiother Oncol Wang Z, Guan W, Bu M, Lu S, Zhao H. PMID: 40517842 [PubMed - as supplied by publisher]
	Body Composition and Inflammation as emerging Sex-specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma undergoing Immune Checkpoint-Inhibition Therapy - a Prospective Pilot Study. Oncol Res Treat Knuever J, Persa O, Gerecht L, Schlaak M, Theurich S. PMID: 40517768 [PubMed - as supplied by publisher]
	Early diagnosis and delayed treatment of anorectal melanoma in a 19-year-old female: A case report. Int J Surg Case Rep Saffaf Y, Arab H, Aldolly A, Terkaoui R, Shikh Saeed M. PMID: 40517678 [PubMed - as supplied by publisher]
	Quantitative response assessment of combined immunotherapy in a murine melanoma model using multiparametric MRI. Eur Radiol Exp Heimer MM, Cimic A, Kloiber-Langhorst S, Antons MJ, Stueckl J, Hirner-Eppeneder H, Kunz WG, Dietrich O, Ricke J, Herr FL, Cyran CC. PMID: 40517176 [PubMed - indexed for MEDLINE]
	Anti-melanoma differentiation-associated gene 5 antibody associated rapidly progressive interstitial lung disease in a pediatric patient: a case report. J Med Case Rep Sirimontakan T, Escobar N, Kritzinger F, Limenis E, Mastrangelo G, Mema B, Mtaweh H. PMID: 40514742 [PubMed - indexed for MEDLINE]
	Nivolumab plus relatlimab in advanced melanoma: RELATIVITY-047 4-year update. Eur J Cancer Lipson EJ, Stephen Hodi F, Tawbi H, Schadendorf D, Ascierto PA, Matamala L, Gutierrez EC, Rutkowski P, Gogas HJ, Lao CD, Menezes JJ, Dalle S, Arance A, Gaudy-Marqueste C, Chen B, Jackson W, Mukherjee S, Dolfi S, Long GV. PMID: 40513285 [PubMed - as supplied by publisher]
	Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025. J Dermatol Fukushima S, Ito T, Asai J, Igaki H, Tanaka R, Namikawa K, Hayashi A, Minagawa A, Miyagawa T, Miyashita A, Ogata D, Okumura M, Kiniwa Y, Goto H, Namiki T, Hashimoto H, Hida T, Hirata T, Maeda T, Matsuzawa T, Yanagi T, Sugimoto K, Kimura E, Koga H, Uchi H, Miyagaki T, Nakamura Y, Inozume T. PMID: 40511899 [PubMed - as supplied by publisher]
	Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations. Int J Mol Sci Kado S, Komine M. PMID: 40508177 [PubMed - indexed for MEDLINE]
	Tumor Microenvironment in Melanoma Brain Metastasis: A New Potential Target? Int J Mol Sci Caruso G, Garcia Moreira CG, Iaboni E, Tripodo M, Ferrarotto R, Abbritti RV, Conte L, Caffo M. PMID: 40507830 [PubMed - indexed for MEDLINE]
	Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis. Cancers (Basel) Gambichler T, Weyer-Fahlbusch SS, Overbeck J, Abu Rached N, Becker JC, Susok L. PMID: 40507352 [PubMed]
	Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma in Older Patients: An Overview of Published Data. Cancers (Basel) Lens M, Schachter J. PMID: 40507314 [PubMed]
	Immunohistochemistry for Skin Cancers: New Insights into Diagnosis and Treatment of Melanoma. Cancers (Basel) Voiculescu VM, Popescu AI, Costache M. PMID: 40507250 [PubMed]
	The Influence of Dietary Factors on Melanoma Development and Progression: A Comprehensive Review. Nutrients Watson AE, Yusuf N. PMID: 40507159 [PubMed - indexed for MEDLINE]
	Genomic and physiological characteristics for survival in melanoma: a genetic epidemiology study. Gene Fletcher LA, Hollar D. PMID: 40506001 [PubMed - as supplied by publisher]
	Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study. Eur J Cancer Mandalà M, Amaral T, Rutkowski P, Sergi MC, Rasch ML, Benannoune N, Serra P, Vitale MG, Giannarelli D, Arance AM, Couselo EM, Neyns B, Dirven I, Tucci M, Guida M, Spagnolo F, Rossi E, Queirolo P, Quaglino P, Depenni R, Placzke J, Giacomo AMD, Del Vecchio M, Indini A, Silva IPD, Menzies AM, Hong A, Lorigan P, Long GV, Robert C, Ascierto PA. PMID: 40505525 [PubMed - as supplied by publisher]
	Management of Cutaneous Melanoma, With a Special Focus on Desmoplastic Melanoma. Am Soc Clin Oncol Educ Book Kendra KL, Contreras CM, Verschraegen CF, Wu RC, Hasanov M. PMID: 40505073 [PubMed - indexed for MEDLINE]
	Employing skin self-examination and fear of cancer recurrence management in early-stage melanoma follow-up: evaluation of the MELACARE intervention in a randomised controlled trial. J Cancer Surviv Hansen SM, Johansen C, Kasparian NA, Grand MK, Bidstrup PE, Hölmich LR. PMID: 40504479 [PubMed - as supplied by publisher]

Articles 1 - 20 / 42926

Page 1 of 2147



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy